Suppression of human T-cell responses to β-cells by activation of B7-H4 pathway

Dawei Ou, Xiaojie Wang, Daniel L. Metzger, Ziliang Ao, Paolo Pozzilli, Roger F L James, Lieping Chen, Garth L. Warnock

Research output: Contribution to journalArticle

Abstract

B7-H4, a recently described member of the B7 family of cosignal molecules, is thought to be involved in the regulation of cellular and humoral immune responses through receptors on activated T and B cells. Human islet cells express positive B7-H4 mRNA in RT-PCR assays, but not B7-H4 protein on cell surface in flow cytometric analyses. To investigate the regulatory effects of activation of the B7-H4 pathway on the function of activated T cells of patients with type 1 diabetes (T1D), we have used our in vitro human experimental system, including human β-cell antigen-specific T-cell clones and human β-cell lines CM and HP62, as well as primary islet cells. B7-H4.Ig protein was purified from the culture supernatant of 293T cells transfected by a B7-H4.Ig plasmid (pMIgV, containing a human B7-H4 cDNA and a mouse IgG2a Fc cDNA). Our preliminary studies showed that immobilized fusion protein human B7-H4.Ig (coated with 5 μg/ml for 2 h at 37°C), but not control Ig, clearly inhibited the proliferation of activated CD4+ and CD8+ T cells of patients induced by anti-CD3 antibody in CFSE assays. B7-H4.Ig also arrested cell cycle progression of T cells in G0/G1 phase and induced T-cell apoptosis as measured by BrdU-7-AAD flow cytometric analysis. To determine the cytoprotective effects of B7-H4, we developed transfectants of human β-cell lines CM and HP62 and islet cells transfected with the B7-H4.Ig plasmid, using empty vector transfectants as controls. The results demonstrate that cell-associated B7-H4.Ig expressed on human β-cells clearly inhibits the cytotoxicity of the T-cell clones to targeted human β-cells in 51Cr release cytotoxicity assays. Activation of the B7-H4 pathway may represent a novel immunotherapeutic approach to inhibit T-cell responses for the prevention of β-cell destruction in T1D.

Original languageEnglish (US)
Pages (from-to)399-410
Number of pages12
JournalCell Transplantation
Volume15
Issue number5
DOIs
StatePublished - 2006

Fingerprint

T-cells
Chemical activation
T-Lymphocytes
Cells
Assays
Islets of Langerhans
Cytotoxicity
Medical problems
Proteins
Type 1 Diabetes Mellitus
Plasmids
Complementary DNA
Clone Cells
Immobilized Proteins
Cell death
Antigens
Cell Line
Cell Cycle Resting Phase
Antibodies
HEK293 Cells

Keywords

  • β-Cell destruction
  • B7-H4
  • Costimulatory molecules
  • Islet cell transplantation
  • Suppression of T-cell responses
  • Type 1 diabetes

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation

Cite this

Ou, D., Wang, X., Metzger, D. L., Ao, Z., Pozzilli, P., James, R. F. L., ... Warnock, G. L. (2006). Suppression of human T-cell responses to β-cells by activation of B7-H4 pathway. Cell Transplantation, 15(5), 399-410. https://doi.org/10.3727/000000006783981837

Suppression of human T-cell responses to β-cells by activation of B7-H4 pathway. / Ou, Dawei; Wang, Xiaojie; Metzger, Daniel L.; Ao, Ziliang; Pozzilli, Paolo; James, Roger F L; Chen, Lieping; Warnock, Garth L.

In: Cell Transplantation, Vol. 15, No. 5, 2006, p. 399-410.

Research output: Contribution to journalArticle

Ou, D, Wang, X, Metzger, DL, Ao, Z, Pozzilli, P, James, RFL, Chen, L & Warnock, GL 2006, 'Suppression of human T-cell responses to β-cells by activation of B7-H4 pathway', Cell Transplantation, vol. 15, no. 5, pp. 399-410. https://doi.org/10.3727/000000006783981837
Ou, Dawei ; Wang, Xiaojie ; Metzger, Daniel L. ; Ao, Ziliang ; Pozzilli, Paolo ; James, Roger F L ; Chen, Lieping ; Warnock, Garth L. / Suppression of human T-cell responses to β-cells by activation of B7-H4 pathway. In: Cell Transplantation. 2006 ; Vol. 15, No. 5. pp. 399-410.
@article{1bf0c3d38884413eae575bd667756982,
title = "Suppression of human T-cell responses to β-cells by activation of B7-H4 pathway",
abstract = "B7-H4, a recently described member of the B7 family of cosignal molecules, is thought to be involved in the regulation of cellular and humoral immune responses through receptors on activated T and B cells. Human islet cells express positive B7-H4 mRNA in RT-PCR assays, but not B7-H4 protein on cell surface in flow cytometric analyses. To investigate the regulatory effects of activation of the B7-H4 pathway on the function of activated T cells of patients with type 1 diabetes (T1D), we have used our in vitro human experimental system, including human β-cell antigen-specific T-cell clones and human β-cell lines CM and HP62, as well as primary islet cells. B7-H4.Ig protein was purified from the culture supernatant of 293T cells transfected by a B7-H4.Ig plasmid (pMIgV, containing a human B7-H4 cDNA and a mouse IgG2a Fc cDNA). Our preliminary studies showed that immobilized fusion protein human B7-H4.Ig (coated with 5 μg/ml for 2 h at 37°C), but not control Ig, clearly inhibited the proliferation of activated CD4+ and CD8+ T cells of patients induced by anti-CD3 antibody in CFSE assays. B7-H4.Ig also arrested cell cycle progression of T cells in G0/G1 phase and induced T-cell apoptosis as measured by BrdU-7-AAD flow cytometric analysis. To determine the cytoprotective effects of B7-H4, we developed transfectants of human β-cell lines CM and HP62 and islet cells transfected with the B7-H4.Ig plasmid, using empty vector transfectants as controls. The results demonstrate that cell-associated B7-H4.Ig expressed on human β-cells clearly inhibits the cytotoxicity of the T-cell clones to targeted human β-cells in 51Cr release cytotoxicity assays. Activation of the B7-H4 pathway may represent a novel immunotherapeutic approach to inhibit T-cell responses for the prevention of β-cell destruction in T1D.",
keywords = "β-Cell destruction, B7-H4, Costimulatory molecules, Islet cell transplantation, Suppression of T-cell responses, Type 1 diabetes",
author = "Dawei Ou and Xiaojie Wang and Metzger, {Daniel L.} and Ziliang Ao and Paolo Pozzilli and James, {Roger F L} and Lieping Chen and Warnock, {Garth L.}",
year = "2006",
doi = "10.3727/000000006783981837",
language = "English (US)",
volume = "15",
pages = "399--410",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "5",

}

TY - JOUR

T1 - Suppression of human T-cell responses to β-cells by activation of B7-H4 pathway

AU - Ou, Dawei

AU - Wang, Xiaojie

AU - Metzger, Daniel L.

AU - Ao, Ziliang

AU - Pozzilli, Paolo

AU - James, Roger F L

AU - Chen, Lieping

AU - Warnock, Garth L.

PY - 2006

Y1 - 2006

N2 - B7-H4, a recently described member of the B7 family of cosignal molecules, is thought to be involved in the regulation of cellular and humoral immune responses through receptors on activated T and B cells. Human islet cells express positive B7-H4 mRNA in RT-PCR assays, but not B7-H4 protein on cell surface in flow cytometric analyses. To investigate the regulatory effects of activation of the B7-H4 pathway on the function of activated T cells of patients with type 1 diabetes (T1D), we have used our in vitro human experimental system, including human β-cell antigen-specific T-cell clones and human β-cell lines CM and HP62, as well as primary islet cells. B7-H4.Ig protein was purified from the culture supernatant of 293T cells transfected by a B7-H4.Ig plasmid (pMIgV, containing a human B7-H4 cDNA and a mouse IgG2a Fc cDNA). Our preliminary studies showed that immobilized fusion protein human B7-H4.Ig (coated with 5 μg/ml for 2 h at 37°C), but not control Ig, clearly inhibited the proliferation of activated CD4+ and CD8+ T cells of patients induced by anti-CD3 antibody in CFSE assays. B7-H4.Ig also arrested cell cycle progression of T cells in G0/G1 phase and induced T-cell apoptosis as measured by BrdU-7-AAD flow cytometric analysis. To determine the cytoprotective effects of B7-H4, we developed transfectants of human β-cell lines CM and HP62 and islet cells transfected with the B7-H4.Ig plasmid, using empty vector transfectants as controls. The results demonstrate that cell-associated B7-H4.Ig expressed on human β-cells clearly inhibits the cytotoxicity of the T-cell clones to targeted human β-cells in 51Cr release cytotoxicity assays. Activation of the B7-H4 pathway may represent a novel immunotherapeutic approach to inhibit T-cell responses for the prevention of β-cell destruction in T1D.

AB - B7-H4, a recently described member of the B7 family of cosignal molecules, is thought to be involved in the regulation of cellular and humoral immune responses through receptors on activated T and B cells. Human islet cells express positive B7-H4 mRNA in RT-PCR assays, but not B7-H4 protein on cell surface in flow cytometric analyses. To investigate the regulatory effects of activation of the B7-H4 pathway on the function of activated T cells of patients with type 1 diabetes (T1D), we have used our in vitro human experimental system, including human β-cell antigen-specific T-cell clones and human β-cell lines CM and HP62, as well as primary islet cells. B7-H4.Ig protein was purified from the culture supernatant of 293T cells transfected by a B7-H4.Ig plasmid (pMIgV, containing a human B7-H4 cDNA and a mouse IgG2a Fc cDNA). Our preliminary studies showed that immobilized fusion protein human B7-H4.Ig (coated with 5 μg/ml for 2 h at 37°C), but not control Ig, clearly inhibited the proliferation of activated CD4+ and CD8+ T cells of patients induced by anti-CD3 antibody in CFSE assays. B7-H4.Ig also arrested cell cycle progression of T cells in G0/G1 phase and induced T-cell apoptosis as measured by BrdU-7-AAD flow cytometric analysis. To determine the cytoprotective effects of B7-H4, we developed transfectants of human β-cell lines CM and HP62 and islet cells transfected with the B7-H4.Ig plasmid, using empty vector transfectants as controls. The results demonstrate that cell-associated B7-H4.Ig expressed on human β-cells clearly inhibits the cytotoxicity of the T-cell clones to targeted human β-cells in 51Cr release cytotoxicity assays. Activation of the B7-H4 pathway may represent a novel immunotherapeutic approach to inhibit T-cell responses for the prevention of β-cell destruction in T1D.

KW - β-Cell destruction

KW - B7-H4

KW - Costimulatory molecules

KW - Islet cell transplantation

KW - Suppression of T-cell responses

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=33748255562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748255562&partnerID=8YFLogxK

U2 - 10.3727/000000006783981837

DO - 10.3727/000000006783981837

M3 - Article

C2 - 16970282

AN - SCOPUS:33748255562

VL - 15

SP - 399

EP - 410

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 5

ER -